Noveris Health Sciences is trading 10% up at CA$1.32 amid ongoing speculative interest and elevated volatility seen over the past week.

  • No fresh company-specific news, earnings, or regulatory headlines were identified for July 24.
  • The move appears driven by short-term trading flows rather than fundamental developments.
  • The stock continues its recent pattern of sharp swings, maintaining a trend of high volatility.